The microencapsulation techniques are widely used in the pharmaceutical field.
The microencapsulation techniques are widely used in the pharmaceutical field. 1) Among them, emulsion solvent evaporation method has taken considerable attention in recent years, and numerous methods to manipulate a drug release behavior have been reported. 2) Several preparation variables influencing on the properties of microspheres have been identified, including solvent type, solvent removal rate, preparation temperature, composition and viscosity of polymer, and drug loading amount. In a previous study, we illustrated the effect of temperature-increase rate in the solvent evaporation process (referred to as the temperature-increase method hereafter) on the drug release property of the microspheres. 3) In this method, the preparative vessel was heated up at the constant rate in order to evaporate the dispersed solvent. By means of the temperature-increase method, microspheres showing constant drug release were prepared over a short period of time. Although a variety of studies has been conducted, the effects of poor solvent in the dispersed phase on the physical properties and drug release characteristics are not well-documented.
The aim of the current work was to evaluate the effects of poor solvent in the dispersed phase on drug release from the microspheres when the temperature-increase method was employed for the emulsion solvent evaporation process. In this study, model microspheres were prepared from theophylline (TH) and hydrophobic dextran derivative (PDME). TH was used as a representative drug since sustained-release formulations are desirable because of the short elimination half-life in humans. PDME was selected as a water-insoluble polymer; it is used for contact lenses in the industrial field. Mixtures of acetone and water were used as the dispersed phase and liquid paraffin as the continuous phase. The microspheres were characterized by their size and drug loading efficiency. The morphology of the microspheres was then observed by scanning electron microscopy. In addition, drug release was examined and its kinetics were analyzed.
MATERIALS AND METHODS
Materials TH as an anhydrous form was purchased from Sigma Chemical Co. (St. Luis, MO, U.S.A.) and was used after sieving through a 200-mesh sieve (less than 75 mm). PDME was kindly donated by Meito Sangyo Co., Ltd. (Nagoya, Japan) and was used without further purification. PDME is prepared from dextran (Mw 40000) by substitution of 0.58 mol acetyl, 0.81 mol propionyl, 1.42 mol butyryl and 0.16 mol methacryloyl per anhydroglucose unit of dextran. Acetone was purchased from Wako Pure Chemical Industry, Ltd. (Osaka, Japan). Liquid paraffin conforming to JP standard was obtained from Iwaki Seiyaku Co., Ltd. (Tokyo, Japan). Sucrose-ester (DKF-10) was generously supplied by Dai-ichi Kogyo Seiyaku Co., Ltd. (Kyoto, Japan) and was used as an emulsifier. Polyoxyethylene (20) sorbitan monolaurate (Tween 20) was purchased from Wako Pure Chemical Industries, Ltd. (Osaka, Japan). Ultra purified water generated by Direct-Q (Nihon Millipore Ltd., Tokyo, Japan) was used for preparation of the dispersed phase. All other chemicals were of special reagent grade and were used as received.
Preparation of Microspheres PDME (6.75 g) was dissolved into 15 ml of a mixture of acetone and water. TH (2.25 g) was then suspended in the PDME solution by stirring with a magnetic stirrer. The resultant suspension was poured into 150 ml of liquid paraffin containing 0.75 g of DKF-10 in a vessel settled into a water bath under agitation (400 rpm, 1 propeller) at 20°C. Following emulsification for 30 min at this temperature in the water bath, the system was heated up to 60°C at the temperature-increase rate of 30°C/h. In order to remove the organic solution completely,
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additional heating for 30 min at 60°C was conducted. After allowing the microspheres to settle and cool to 20°C, the clear supernatant liquid paraffin was decanted into a waste bottle. The microspheres were washed three times with 50 ml of n-hexane and then dried under reduced pressure at room temperature overnight.
The preparative variables are summarized in Table 1 . Recovery and Particle Size Product recovery was determined from the weight ratio of dried microspheres to the loaded drug and polymer. Drug content was analyzed as follows. Microspheres containing approximately 10 mg of TH were accurately weighed and dissolved completely in methylene chloride, and then the drug concentration was determined spectrophotometrically at 274 nm.
Particle size and distribution of the microspheres were determined by sieving through a set of standard sieves with openings of 300, 355, 425, 500, 600, 710, 850, 1000, 1180, 1400 and 1700 mm. Each sample was placed on the uppermost sieve and shaken enough to separate. The individual sieves were weighed to determine the amounts of microspheres retained. From the weight distribution, the geometric mean diameter was calculated for each sample.
The microspheres with diameters of 600-1400 mm were used for further studies.
Scanning Electron Microscopy (SEM) Surface and internal morphologies of microspheres were observed with a scanning electron microscope (JSM-5600LV, JEOL, Japan). Prior to the observation, the samples were coated with gold using a vacuum evaporator.
Release Test In vitro drug release studies were carried out at 37Ϯ0.5°C in 900 ml of JPXIV 1st fluid (pH 1.2, 0.07 M HCl and 0.0342 M NaCl) with 0.02% Tween 20 using a standard JPXIV dissolution apparatus with paddle stirrers (100 rpm). Five-milliliter samples were withdrawn from the dissolution vessels at 0.25, 0.5, 1, 2, 4, 6, and 8 h and immediately replaced with an equal volume of the same test fluid. Samples were filtered with a membrane filter (pore size 0.45 mm). The filtrate was analyzed spectrophotometrically at 274 nm for TH content. The experiments were repeated three times.
RESULTS

Recovery and Particle Size
Microspheres prepared using various amounts of poor solvent in the dispersed phase were spherical in shape, free flowing, and non-aggregated. Particle characteristics are summarized in Table 2 . Product recovery varied from 84.2 to 93.4%, and drug content was about 30%. These results indicated that the microspheres were appropriate for evaluation of the poor solvent effects.
The mean diameter was slightly increased as the amount of the poor solvent increased. This was due to the increase in viscosity of the dispersed phase caused by decreased acetone volume. In general, increase in viscosity of the dispersed phase resulted in increased mean droplet size. 4) Moreover, addition of poor solvent to the polymer solution led to a reduction in solubility, resulting in a faster deposition of the polymer in the primary emulsion.
Surface Morphology and Internal Structure Surface morphology and internal structure of the microspheres were examined by SEM. Figure 1 shows the appearance and crosssection of the microspheres. S0.5 had a rough surface with protruding drug crystals (Fig. 1a) . From the cross-section, TH was distributed over the entire microsphere (Fig. 1b) . In contrast, S1.5 and S2.0 showed apparently smooth surfaces (Figs. 1e, g ). TH tended to become segregated from the polymer matrix as the amount of water increased as shown in Figs. 1f and h. The formulation variables were kept the same, whereas their structure differed. Generally, microspheres prepared by emulsion solvent evaporation method show a monolithic structure. This has been reported even in the case of the addition of poor solvent into the dispersed medium. 5) In contrast, a complete core-shell structure was observed in the case of S2.0 (Fig. 1h) . This surprising finding suggested that the amount of the poor solvent in the dispersed phase was a crucial factor determining the internal structure of microspheres.
Drug Release Behaviors The release profiles of TH from the microspheres prepared using various amounts of water are shown in Fig. 2 . The drug release was significantly affected by the amount of water; as the amount of water increased, the drug release rate decreased. Only 23% of TH was released from S2.0 during 8 h, while more than 80% of the drug was released from S0.5 in the same period. Yang C.-Y., et al. reported that drug release was accelerated by addition of poor solvent in order of increasing poor solvent in the dispersed medium. 5) They also observed the microspheres with a coarser surface and larger pores when the larger amount of poor solvent was added. Therefore, the reverse order of drug release rate was due to the difference in structure of the microspheres.
Kinetics of Drug Release In order to examine the kinetics of drug release from the microspheres, the release data (Ϲ70%) were fitted to the following power law equation. 6) M t /M ϱ ϭkt n (1) where M t /M ϱ is the fraction of drug released at time t, k is the coefficient constant which accounts for the structural and geometrical properties of the matrix, and n is the diffusional exponent indicative of the mechanism of drug release. According to Ritger P. L. and Peppas N. A., values of the exponent nϭ0.5, 0.5ϽnϽ1, and nϭ1.0 indicate Fickian diffusion, non-Fickian diffusion and zero-order transport, respectively.
6) The results are summarized in Table 3 . The release data for the microspheres give a good fit in Eq. 1. As seen in Table 3 , the values of diffusional exponent, n, for the microspheres, S0.5-S2.0, were sifted from 0.469 to 1.09 as the amount of water increased from 0.5 to 2.0 ml, respectively. These results demonstrated that the mechanism of drug release from the microspheres was dramatically altered from matrix diffusion to zero-order kinetic by only a small change in the amount of water. This result was supported by the structural change, as shown in Fig. 1 , because core-shell structure was thought to be involved in zero-order kinetic.
Moreover, the diffusional exponent was represented as a linear function of the amount of water, as shown in Fig. 3 . This result suggested that the drug release mechanisms of the microspheres could be controlled by the amount of water, ranging from 0.5 to 2 ml.
DISCUSSION
In order to manipulate drug release rate from microspheres, many factors have been investigated. 1) There are, however, few reports evaluating the effects of poor solvent addition to the dispersed phase. In this study, TH microspheres were fabricated by the emulsion solvent evaporation method using a solvent/poor solvent mixture as the dispersed phase. The results revealed that the amount of the poor solvent in the dispersed phase greatly impacted the structure and properties of the microspheres. The structure of the microspheres was changed from monolithic type to reservoir type (Fig. 1) . In addition, the drug release mechanism was proportionately shifted from Fickian diffusion to zero-order transport (Fig. 3) . These findings are very important for microencapsulation techniques based on emulsion solvent evaporation method.
Previously, the addition of poor solvent into the dispersed medium (referred to as the poor solvent addition method hereafter) was examined in order to save time for emulsion solvent removal. 7) Subsequently, the morphology and drug release property of the microspheres prepared by the poor solvent addition method were analyzed. 5, 8) Consequently, microspheres with a coarser surface and rapid drug release property were obtained in exchange for a reduction in particle size or improvement in product recovery. Therefore, the poor solvent addition method was thought to be a marginal method having few pitfalls with respect to the performance of the microspheres. In contrast, we achieved remarkable performance by combining the poor solvent addition method and the temperatureincrease method as described herein. By concomitant use of the temperature-increase method, 3) the solvent evaporation rate from the droplets to the dispersion medium was accelerated, and the polymer dissolved in the emulsion was rapidly deposited, forming a rigid outer-shell on the surface of the emulsion. Thereby, the drug and water would remain within the polymer shell. Water was then disposed of slowly. Thus, the surface of the microspheres became smoother and the structure became a core-shell type, as the amount of the poor solvent increased.
Thus, we demonstrated that the structure of microspheres was controlled by addition of only a small amount of the poor solvent to the dispersed phase. At the same time, the drug release mechanism was found to be controllable over a wide range of kinetics (Fig. 3) .
Besides the structure of microspheres, the chemical properties associated with both the drug and polymer affect the drug release rate. 9, 10) Moreover, TH release from polymeric microspheres depends on various factors including the polymer composition, polymer molecular weight, and drug loading. [11] [12] [13] Therefore, the drug release rate from the microspheres could be modulated by these factors once the drug release mechanism is controlled by the present method. CONCLUSION TH microspheres were prepared by the temperature-increase method using a solvent/poor solvent mixture as the dispersed phase. The amount of the poor solvent greatly influenced the physical properties and drug release mechanism of the microspheres. By use of a larger amount of the poor solvent, a core-shell structure was obtained. By changing the amount of the poor solvent, from small to large volume, the release kinetics were altered from Fickian diffusion to zeroorder transport, respectively. The results demonstrated that the structure and drug release mechanism of the microspheres was easily controlled by use of solvent/poor solvent mixture as a dispersed phase.
